Pfizer Takes Aim At Moderna's Leftover MRNA Protections
Pfizer asked an appeals court Thursday to revoke surplus patent protections underpinning rival Moderna's mRNA vaccine after getting a key patent tossed....To view the full article, register now.
Already a subscriber? Click here to view full article